Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Teva To Launch First Generic EpiPen In 'Coming Months'; FDA Heralds Approval Of Complex Product

16 Aug 2018

• By Brenda Sandburg

Related Content

Mylan Communications With CMS To Get Outside Review Under EpiPen Settlement

17 Aug 2017

EpiPen Pricing Got Mylan In Hot Water; Now Sanofi Is Taking Firm To Court

25 Apr 2017

Mylan To Explore Strategic Options, Claiming Investors Have Failed To Appreciate The Value

08 Aug 2018

Express Scripts Rewards Low List-Priced Brands In 2019 Formulary, Retains Focus On Rebates

07 Aug 2018

Mylan’s EpiPen Defense Against Generics Focuses On Device Design

22 Jan 2015

Mylan’s EpiPen Exclusivity Saved Again As Teva Reports CRL

01 Mar 2016

EpiPen Generics: Woodcock Explains Injector Studies

22 Sep 2016

Related Companies

Teva Pharmaceutical Industries Ltd.

Viatris Inc.

Express Scripts Holding Company

Amneal Pharmaceuticals, Inc.

Lineage Biomedical Inc.

Amneal Pharmaceuticals, Inc.

Merck KGaA

Sanofi

Additional Topics

United States Regulation Approvals Generic Drugs FDA BioPharmaceutical

More from Approvals

More from Product Reviews

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.